Donn Young is the former director of the Ohio State University Comprehensive Cancer Center Biostatistics Unit where he spent ...

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...

The aggressiveness of a cancer is based on several factors, including the tumor's grade and stage, and the cells' genetic ...

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...

When the news broke about former president Joe Biden’s prostate cancer, I wasn’t surprised. Cancer touches almost everyone ...

Developing tests that better identify patients at risk of dying from prostate cancer can decrease overtreatment. In the ...

HBCU Legends dives into the pulse of HBCU sports—covering everything from breaking health news and prostate cancer awareness ...

EXCLUSIVE: A leading authority in prostate treatment and urology has given his insights on a condition that can affect 1 in 8 ...